Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 1.10 is 11% below its 4-year average of 1.24, around the middle of its 4-year range (0.00–2.90).
As of the fiscal period ended Tuesday, June 30, 2026. 12.53% below its 12-month average of 1.26.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.10.
DEBT TO EQUITY RATIO
1.10
DEBT TO EQUITY RATIO AVG TTM
1.26
DEBT TO EQUITY RATIO AVG 3Y
1.72
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.53%
CURRENT VS 3Y AVG
-35.82%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.69
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+60.77%
vs the sector median at left
Solventum Corporation
Market Cap
$15.21B
Debt to Equity Ratio
1.10
TTM Avg
1.26
3Y Avg
1.72
5Y Avg
N/A
Market Cap
$16.30B
Debt to Equity Ratio
0.28
TTM Avg
0.36
3Y Avg
0.37
5Y Avg
0.29
Market Cap
$13.12B
Debt to Equity Ratio
1.07
TTM Avg
0.88
3Y Avg
0.91
5Y Avg
0.99
Market Cap
$17.75B
Debt to Equity Ratio
0.59
TTM Avg
0.54
3Y Avg
0.51
5Y Avg
0.54
Market Cap
$12.44B
Debt to Equity Ratio
1.56
TTM Avg
1.78
3Y Avg
2.05
5Y Avg
1.83
Market Cap
$11.97B
Debt to Equity Ratio
1.09
TTM Avg
1.21
3Y Avg
1.62
5Y Avg
1.75
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.21B | 1.10 | 1.26 | 1.72 | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.47B | 0.09 | 0.08 | 0.08 | 0.07 |
| Medpace Holdings, Inc. (MEDP)vs › | $16.30B | 0.28 | 0.36 | 0.37 | 0.29 |
| Revvity, Inc. (RVTY)vs › | $13.51B | 0.46 | 0.45 | 0.51 | 0.56 |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.12B | 1.07 | 0.88 | 0.91 | 0.99 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.75B | 0.59 | 0.54 | 0.51 | 0.54 |
| Penumbra, Inc. (PEN)vs › | $12.52B | 0.14 | 0.17 | 0.20 | 0.18 |
| Baxter International Inc. (BAX)vs › | $12.44B | 1.56 | 1.78 | 2.05 | 1.83 |
| Encompass Health Corporation (EHC)vs › | $11.97B | 1.09 | 1.21 | 1.62 | 1.75 |
| DaVita Inc. (DVA)vs › | $11.66B | N/A | 55.08 | 35.65 | 25.99 |
Debt/Equity
1.10
Current Ratio
1.02
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 1.10 |
| 2026-03-31 | 1.02 |
| 2025-12-31 | 1.00 |
| 2025-09-30 | 1.03 |
| 2025-06-30 | 2.14 |
| 2025-03-31 | 2.43 |
| 2024-12-31 | 2.71 |
| 2024-09-30 | 2.54 |
| 2024-06-30 | 2.90 |
| 2024-03-31 | 2.16 |
| 2023-12-31 | 0.71 |
| 2023-09-30 | 2.56 |
| 2023-06-30 | 0.01 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
